Cleared Traditional

K912728 - ALTAIR

K912728 is an FDA 510(k) clearance for ALTAIR, manufactured by Diagnostic Medical Instruments. The device is a Class 2 Cardiovascular device with product code DQK cleared through the Traditional 510(k) pathway after a 252-day FDA review.

Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Feb 1992
Decision
252d
Days
Class 2
Risk

K912728 is an FDA 510(k) clearance for the ALTAIR. Classified as Computer, Diagnostic, Programmable (product code DQK), Class II - Special Controls.

Submitted by Diagnostic Medical Instruments (Syracuse, US). The FDA issued a Cleared decision on February 27, 1992 after a review of 252 days - an extended review cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.1425 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Standard predicate-based submission. Standard predicate reliance. This clearance follows a standard predicate-based equivalence path within the Cardiovascular review framework, consistent with the majority of Class II 510(k) submissions.

FDA 510(k) Submission Details - K912728

510(k) Number K912728 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received June 20, 1991
Decision Date February 27, 1992
Days to Decision 252 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary Statement
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
127d slower than avg
Panel avg: 125d · This submission: 252d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

DQK Device Classification - Class 2, Special Controls

Product Code DQK Computer, Diagnostic, Programmable
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.1425
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - DQK Computer, Diagnostic, Programmable

All 440
Devices cleared under the same product code (DQK) and FDA review panel - the closest regulatory comparables to K912728.
OFF-LINE ANALYSIS SYSTEM
K921216 · Softheart, Inc. · Nov 1992
MEDILOG EXCEL ECG ANALYSIS SYSTEM (MODIFIED)
K920295 · Oxford Medilog, Inc. · Aug 1992
RHYTHMSCAN PRECISION 6000
K914577 · Precision Health Care Systems, Inc. · May 1992
CATHWRITER(TM)
K914105 · Softheart, Inc. · Feb 1992
HOLTER 24-HOUR ECG SYSTEM, MODEL NUMBER: DMS 300
K911615 · Diagnostic Monitoring Software · Jan 1992
MODEL 100 CENTRAL STATION
K913193 · Protocol Systems, Inc. · Oct 1991